Health Catalyst Inc. Revenue 2017–2025
Health Catalyst Inc. annual/quarterly revenue history and growth rate from 2017 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Health Catalyst Inc. revenue for the quarter ending March 31, 2026 was 70.8 M, a 10.90% decrease year-over-year.
- Health Catalyst Inc. revenue for the twelve months ending March 31, 2026 was 307.2 M, a 2.15% increase year-over-year.
- Health Catalyst Inc. annual revenue for 2025 was 311.1 M, a 1.48% increase from 2024.
- Health Catalyst Inc. annual revenue for 2024 was 306.6 M, a 3.60% increase from 2023.
- Health Catalyst Inc. annual revenue for 2023 was 295.9 M, a 7.13% increase from 2022.
- Health Catalyst Inc. annual revenue for 2022 was 276.2 M.
Health Catalyst Inc. (HCAT) — Frequently Asked Questions
Health Catalyst Inc. (HCAT) is a publicly traded US company. It has a market capitalization of $110M. In fiscal 2025 it reported revenue of $311M and net income of -$178M. Explore HCAT's stock price, financial statements, earnings history, margins and key ratios below.
What is Health Catalyst Inc.'s market cap?
Health Catalyst Inc. (HCAT) has a market capitalization of $110M.
What is the HCAT stock price?
HCAT trades at $1.58 (-1.25% on the day).
How much revenue does Health Catalyst Inc. make?
Health Catalyst Inc. reported revenue of $311M in fiscal 2025.
Is HCAT profitable?
In fiscal 2025, Health Catalyst Inc. reported net income of -$178M.